Company news
Lushang Freda Pharmaceutical Co., Ltd. news in 2026
Lushang Freda Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Report for Q3 2026
October 27, 2026
(600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Key Operating Data for Q3 2026
October 27, 2026
(600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
October 27, 2026
(600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Appointment of Senior Executives
October 16, 2026
(600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Departure of Director and Senior Executive
October 13, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
September 11, 2026
Announcement on Completion of Transfer Registration of Certain Company Shares by the Controlling Shareholder through Agreement
September 1, 2026
Notice on Convening the 2nd Extraordinary General Meeting in 2026
August 25, 2026
Announcement on Signing of the Financial Services Agreement with Shandong Commercial Group Finance Co., Ltd. and Related Party Transactions
August 14, 2026
Announcement on Progress in Transfer of Certain Company Shares under Agreement by Controlling Shareholder and Changes in Equity Interests
August 11, 2026
Indicative Announcement on Agreement-based Transfer of Certain Company Shares by Controlling Shareholder and Changes in Equity Interests
August 6, 2026
Announcement on Implementation of Dividend Distribution for 2025
July 6, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 16, 2026
Announcement on Convening the Q1 2026 Performance Briefing
May 26, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
May 12, 2026
Announcement on Convening the 2025 Annual Performance Briefing
April 27, 2026
Announcement on the Ongoing Risk Assessment Report of Shandong Commercial Group Finance Co., Ltd.
April 2, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
January 14, 2026